Cargando…

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients

Early diagnosis of Parkinson’s disease (PD) continues to be a major challenge in the field. The lack of a robust biomarker to detect early stage PD patients has considerably slowed the progress toward the development of potential therapeutic agents. We have previously evaluated several RNA biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Santiago, Jose A., Potashkin, Judith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643881/
https://www.ncbi.nlm.nih.gov/pubmed/26566043
http://dx.doi.org/10.1371/journal.pone.0142582